Gut

Gut Journal

Publication venue for

ALGORITHMS USING NONINVASIVE TESTS CAN ACCURATELY IDENTIFY PATIENTS WITH ADVANCED FIBROSIS DUE TO NASH: DATA FROM THE STELLAR CLINICAL TRIALS. 68:A135-A136. 2019
ROUTINELY AVAILABLE NONINVASIVE TESTS DISCRIMINATE ADVANCED FIBROSIS DUE TO NASH IN THE PHASE 3 STELLAR TRIALS OF THE ASK1 INHIBITOR SELONSERTIB. 68:A136-A137. 2019

International Standard Serial Number (ISSN)

0017-5749